These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10588973)

  • 1. Lessons from secretin.
    Volkmar FR
    N Engl J Med; 1999 Dec; 341(24):1842-4. PubMed ID: 10588973
    [No Abstract]   [Full Text] [Related]  

  • 2. Secretin treatment for autism.
    Rimland B
    N Engl J Med; 2000 Apr; 342(16):1216-7; author reply 1218. PubMed ID: 10777377
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder.
    Sandler AD; Sutton KA; DeWeese J; Girardi MA; Sheppard V; Bodfish JW
    N Engl J Med; 1999 Dec; 341(24):1801-6. PubMed ID: 10588965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretin is an ineffective treatment for pervasive developmental disabilities: a review of 15 double-blind randomized controlled trials.
    Sturmey P
    Res Dev Disabil; 2005; 26(1):87-97. PubMed ID: 15590241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretin treatment for autism.
    Horvath K
    N Engl J Med; 2000 Apr; 342(16):1216; author reply 1218. PubMed ID: 10777376
    [No Abstract]   [Full Text] [Related]  

  • 6. Secretin treatment for autism.
    Herlihy WC
    N Engl J Med; 2000 Apr; 342(16):1217; author reply 1218. PubMed ID: 10777378
    [No Abstract]   [Full Text] [Related]  

  • 7. The autistic-spectrum disorders.
    Rapin I
    N Engl J Med; 2002 Aug; 347(5):302-3. PubMed ID: 12151466
    [No Abstract]   [Full Text] [Related]  

  • 8. Secretin treatment for autism.
    Said SI; Bodanszky M
    N Engl J Med; 2000 Apr; 342(16):1217-8. PubMed ID: 10777379
    [No Abstract]   [Full Text] [Related]  

  • 9. [Medical treatment of pervasive developmental disorders].
    Fuentes J; Gallano I
    Rev Neurol; 2001 Aug 1-15; 33(3):208-10. PubMed ID: 11588711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone in a very young child with PDD.
    Bober D; Sabzwari U; Star JE
    J Am Acad Child Adolesc Psychiatry; 2005 Aug; 44(8):725-6. PubMed ID: 16034272
    [No Abstract]   [Full Text] [Related]  

  • 11. Multisite, double-blind, placebo-controlled trial of porcine secretin in autism.
    Owley T; McMahon W; Cook EH; Laulhere T; South M; Mays LZ; Shernoff ES; Lainhart J; Modahl CB; Corsello C; Ozonoff S; Risi S; Lord C; Leventhal BL; Filipek PA
    J Am Acad Child Adolesc Psychiatry; 2001 Nov; 40(11):1293-9. PubMed ID: 11699803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of risperidone in developmentally disabled children.
    Kastner TA
    Pediatrics; 2005 May; 115(5):1447-8; author reply 1448. PubMed ID: 15867075
    [No Abstract]   [Full Text] [Related]  

  • 13. Development. Desperate parents spark search for new treatment.
    Stokstad E
    Science; 2001 Oct; 294(5540):37. PubMed ID: 11588235
    [No Abstract]   [Full Text] [Related]  

  • 14. [The use of psychopharmaceutical agents in children].
    Minderaa RB; Intveld AN; Vink HJ
    Ned Tijdschr Geneeskd; 1989 Feb; 133(5):252-6. PubMed ID: 2927536
    [No Abstract]   [Full Text] [Related]  

  • 15. Is secretin effective in treatment for autism spectrum disorders (ASD)?
    Jayachandra S
    Int J Psychiatry Med; 2005; 35(1):99-101. PubMed ID: 15977948
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacotherapy of irritability in pervasive developmental disorders.
    Stigler KA; McDougle CJ
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):739-52, vii-viii. PubMed ID: 18775367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders.
    Findling RL
    J Clin Psychiatry; 2005; 66 Suppl 10():26-31. PubMed ID: 16401147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatment options for autism spectrum disorders in children and adolescents.
    Leskovec TJ; Rowles BM; Findling RL
    Harv Rev Psychiatry; 2008; 16(2):97-112. PubMed ID: 18415882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating autistic spectrum disorders in children: utility of the cholinesterase inhibitor rivastigmine tartrate.
    Chez MG; Aimonovitch M; Buchanan T; Mrazek S; Tremb RJ
    J Child Neurol; 2004 Mar; 19(3):165-9. PubMed ID: 15119476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of medication in pervasive developmental disorders.
    Sloman L
    Psychiatr Clin North Am; 1991 Mar; 14(1):165-82. PubMed ID: 1675463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.